BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23244480)

  • 1. HPV detection methods and genotyping techniques in screening for cervical cancer.
    Eide ML; Debaque H
    Ann Pathol; 2012 Dec; 32(6):e15-23, 401-9. PubMed ID: 23244480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and type-specific real-time PCR].
    Sahiner F; Gümral R; Sener K; Yiğit N; Dede M; Yapar M; Kubar A
    Mikrobiyol Bul; 2012 Oct; 46(4):624-36. PubMed ID: 23188576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer.
    Castle PE; Dockter J; Giachetti C; Garcia FA; McCormick MK; Mitchell AL; Holladay EB; Kolk DP
    Clin Cancer Res; 2007 May; 13(9):2599-605. PubMed ID: 17473189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
    Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
    J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.
    Silling S; Kreuter A; Hellmich M; Swoboda J; Pfister H; Wieland U
    J Clin Virol; 2012 Apr; 53(4):325-31. PubMed ID: 22261122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study).
    Monsonego J; Hudgens MG; Zerat L; Zerat JC; Syrjänen K; Smith JS
    Gynecol Oncol; 2012 Apr; 125(1):175-80. PubMed ID: 22233689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of E6/E7 mRNAs of high risk human papilloma virus types by a commercial automatized NASBA assay in cervical swabs].
    Ardiç N; Oztürk O; Ergünay K; Sezer O
    Mikrobiyol Bul; 2009 Jul; 43(3):463-9. PubMed ID: 19795622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.
    Andersson E; Kärrberg C; Rådberg T; Blomqvist L; Zetterqvist BM; Ryd W; Lindh M; Horal P
    J Clin Virol; 2012 May; 54(1):61-5. PubMed ID: 22326759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
    Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
    Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping.
    Lee HP; Cho W; Bae JM; Shin JY; Shin SK; Hwang SY; Min KT; Kim SN; Lee SJ; Kim SO; Yoo WD; Hong SP
    J Clin Virol; 2013 Jun; 57(2):130-5. PubMed ID: 23410688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
    Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
    Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of three methods for HPV DNA detection in cervical samples.
    Michelli E; Téllez L; Mendoza JA; Jürgensen C; Muñoz M; Pérez S; Mosqueda N; Hernández E; Noguera ME; Callejas D; Correnti M; Cavazza ME; Vielma S
    Invest Clin; 2011 Dec; 52(4):344-57. PubMed ID: 22523844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring.
    Cuschieri KS; Whitley MJ; Cubie HA
    J Med Virol; 2004 May; 73(1):65-70. PubMed ID: 15042650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of the RNA-based HPV test in the diagnostics of cervical epithelial changes].
    Doganov A; Kostova P; Boyanova M; Velcheva D; Tchoncheva V; Mainhard K; Zlatkov V
    Akush Ginekol (Sofiia); 2012; 51(3):22-4. PubMed ID: 23236661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a novel microplate colorimetric hybridization genotyping assay for human papillomavirus.
    Barcellos RB; Almeida SE; Sperhacke RD; Verza M; Rosso F; Medeiros RM; Perizzolo PF; Cortez-Herrera E; Rossetti ML
    J Virol Methods; 2011 Oct; 177(1):38-43. PubMed ID: 21807028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
    Nagai N
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digene HPV Genotyping RH Test RUO: comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes.
    Seme K; Lepej SZ; Lunar MM; Iscić-Bes J; Planinić A; Kocjan BJ; Vince A; Poljak M
    J Clin Virol; 2009 Oct; 46(2):176-9. PubMed ID: 19683958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.
    Molden T; Kraus I; Skomedal H; Nordstrøm T; Karlsen F
    J Virol Methods; 2007 Jun; 142(1-2):204-12. PubMed ID: 17379322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biased amplification of human papillomavirus DNA in specimens containing multiple human papillomavirus types by PCR with consensus primers.
    Mori S; Nakao S; Kukimoto I; Kusumoto-Matsuo R; Kondo K; Kanda T
    Cancer Sci; 2011 Jun; 102(6):1223-7. PubMed ID: 21388488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.